HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 0.35
Day range
kr 0.34 - kr 0.36
Year range
kr 0.24 - kr 3.15
Market cap
109.58M SEK
Avg Volume
3.81M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 201.00K | 28.85% |
Operating expense | 19.11M | -22.83% |
Net income | -57.79M | -1,861.71% |
Net profit margin | -28.75K | -1,422.52% |
Earnings per share | -0.24 | — |
EBITDA | -15.47M | 28.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 37.67M | -26.40% |
Total assets | 43.79M | -38.35% |
Total liabilities | 14.53M | -46.84% |
Total equity | 29.26M | — |
Shares outstanding | 241.42M | — |
Price to book | 2.88 | — |
Return on assets | -123.04% | — |
Return on capital | -226.70% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -57.79M | -1,861.71% |
Cash from operations | -24.36M | 0.23% |
Cash from investing | — | — |
Cash from financing | 36.90M | 2,502.54% |
Net change in cash | 12.35M | 148.23% |
Free cash flow | -37.08M | -68.47% |
About
Founded
2007
Website
Employees
9
